Plastic Surgery · Los Angeles, CA
NPI
1205071073
Since 2008
Specialty
Plastic Surgery
Code 208200000X
Group practices
6
Medicare group memberships
Hospitals
3
Hospital affiliations
11645 Wilshire Blvd Ste 1155
Los Angeles, CA, 90025
Phone (424) 293-8861
Groups this clinician bills Medicare through
Medicare paid, 2024
$398K
2,574 services
Medicare patients, 2024
292
Average age 73
Drug cost, 2024
$117K
377 prescriptions
Company payments, 2025
$168
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Murtaza Rizvi was code J1010 (injection, methylprednisolone acetate, 1 mg), 1,151 times for 25 patients. In total Murtaza Rizvi billed 2,574 services in 152 codes, and Medicare paid $398K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-04-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 1,151 | 25 | $0.10 | $118 |
| 99214 Office E&M - Established | Office | 223 | 103 | $106.82 | $24K |
| 99213 Office E&M - Established | Facility | 93 | 71 | $54.58 | $5,075 |
| 73110 X-ray - Upper Extremity | Office | 83 | 37 | $36.75 | $3,051 |
| 99204 Office E&M - New | Office | 80 | 80 | $130.15 | $10K |
| 26145 Musculoskeletal | Facility | 77 | 20 | $225.09 | $17K |
| 15736 Skin | Facility | 61 | 44 | $890.86 | $54K |
| 73130 X-ray - Upper Extremity | Office | 51 | 38 | $33.96 | $1,732 |
| 99203 Office E&M - New | Facility | 35 | 35 | $67.59 | $2,366 |
| 29125 Musculoskeletal | Office | 30 | 19 | $59.14 | $1,774 |
| 20550 Musculoskeletal | Facility | 28 | 23 | $29.57 | $828 |
| 99214 Office E&M - Established | Facility | 23 | 21 | $80.72 | $1,857 |
| Q4022 Cast supplies, short arm splint, adult (11 years +), fiberglass | Office | 19 | 12 | $11.63 | $221 |
| 97760 Occupational Therapy | Office | 18 | 17 | $42.40 | $763 |
| 99212 Office E&M - Established | Facility | 16 | 15 | $29.16 | $467 |
By year: 2022 $136K for 687 services; 2023 $175K for 731 services; 2024 $398K for 2,574 services.
Medicare prescription drug claims, 2024
In 2024, the drug Murtaza Rizvi prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 115 prescriptions and refills. In total Murtaza Rizvi wrote 377 Medicare prescriptions that cost $117K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 115 | 115 | 75 | $839 |
| Cephalexin Generic | 86 | 86 | 67 | $660 |
| Lofena Diclofenac Potassium | 40 | 40 | 29 | $76K |
| Ibuprofen Generic | 23 | 24 | 19 | $164 |
| Naproxen Sodium Cr Naproxen Sodium | 20 | 20 | 18 | $20K |
| Diclofenac Sodium Generic | 19 | 25 | 18 | $398 |
Brand drugs: 24 claims; generic drugs: 353 claims; opioid claims: 134.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Murtaza Rizvi $168 ($168 in general payments such as food, travel and fees) from 5 companies. The largest payer was Bioventus LLC with $51.35.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.